Literature DB >> 15807797

High risk of Mycobacterium tuberculosis infection during the Hajj pilgrimage.

Annelies Wilder-Smith1, Winnie Foo, Arul Earnest, Nicholas I Paton.   

Abstract

INTRODUCTION: Annually more than 2 million pilgrims from all over the world attend the Hajj in Saudi Arabia. Overcrowding during this pilgrimage leads to a high risk of transmission of airborne infectious diseases. Tuberculosis (TB) is common among hospitalized pilgrims, but the overall risk of acquiring Mycobacterium tuberculosis infection during this pilgrimage is not known. We conducted a prospective study to assess the risk of M. tuberculosis infection among Hajj pilgrims.
METHODS: We measured the immune response to TB antigens using a whole-blood assay (QuantiFERON TB assay) prior to departure and 3 months after return from the Hajj pilgrimage.
RESULTS: Of 357 paired assays, 149 pilgrims were negative prior to the Hajj and 15 (10%) of these had a significant rise in immune response to TB antigens.
CONCLUSIONS: Pilgrims may be at high risk of acquiring M. tuberculosis infection during the Hajj. This has significant public health implications for TB control in countries with large Muslim populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15807797     DOI: 10.1111/j.1365-3156.2005.01395.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  20 in total

Review 1.  Prevention of pneumococcal infections during mass gathering.

Authors:  Jaffar A Al-Tawfiq; Ziad A Memish
Journal:  Hum Vaccin Immunother       Date:  2015-07-15       Impact factor: 3.452

2.  Undiagnosed Active Pulmonary Tuberculosis among Pilgrims during the 2015 Hajj Mass Gathering: A Prospective Cross-sectional Study.

Authors:  Saber Yezli; Alimuddin Zumla; Yara Yassin; Ali M Al-Shangiti; Gamal Mohamed; Abdulhafiz M Turkistani; Badriah Alotaibi
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

3.  Intestinal tuberculosis and Crohn's disease: the dilemma of similarities and misdiagnosis.

Authors:  Hisham O Akbar
Journal:  BMJ Case Rep       Date:  2009-12-22

4.  Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.

Authors:  Sahal Al-Hajoj; Bright Varghese; Mohammed M Shoukri; Ruba Al-Omari; Mais Al-Herbwai; Fahad Alrabiah; Abdulrahman A Alrajhi; Naila Abuljadayel; Sahar Al-Thawadi; Alimuddin Zumla; Matteo Zignol; Mario C Raviglione; Ziad Memish
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

5.  Respiratory tract infection during Hajj.

Authors:  Abdulaziz H Alzeer
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

6.  Clinical and temporal patterns of severe pneumonia causing critical illness during Hajj.

Authors:  Yasser Mandourah; Assim Al-Radi; Ali Harold Ocheltree; Sara Rashid Ocheltree; Robert A Fowler
Journal:  BMC Infect Dis       Date:  2012-05-16       Impact factor: 3.090

7.  Tuberculosis trends in Saudis and non-Saudis in the Kingdom of Saudi Arabia--a 10 year retrospective study (2000-2009).

Authors:  Mohammad S Abouzeid; Alimuddin I Zumla; Shaza Felemban; Badriah Alotaibi; Justin O'Grady; Ziad A Memish
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

Review 8.  New digital technologies for the surveillance of infectious diseases at mass gathering events.

Authors:  E O Nsoesie; S A Kluberg; S R Mekaru; M S Majumder; K Khan; S I Hay; J S Brownstein
Journal:  Clin Microbiol Infect       Date:  2014-12-31       Impact factor: 8.067

9.  Causes of mortality for Indonesian Hajj Pilgrims: comparison between routine death certificate and verbal autopsy findings.

Authors:  Masdalina Pane; Sholah Imari; Qomariah Alwi; I Nyoman Kandun; Alex R Cook; Gina Samaan
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

10.  Admixed phylogenetic distribution of drug resistant Mycobacterium tuberculosis in Saudi Arabia.

Authors:  Bright Varghese; Philip Supply; Caroline Allix-Béguec; Mohammed Shoukri; Ruba Al-Omari; Mais Herbawi; Sahal Al-Hajoj
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.